Ars Pharmaceuticals Inc (SPRY)

Investing Cash Flow

$48.50M

TTM · Period ending: · USD

SPRY logo

SPRY Investing Cash Flow

Latest reported$48.50M
SPRY Cash from Investing (-$449.00K → $48.50M)
High-resolution chart · PNG

SPRY investing cash flow history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ars Pharmaceuticals Inc Investing Cash Flow — Annual fiscal periods (USD)
Period endingInvesting Cash Flow (USD)
56,768,000
-106,101,000
-87,180,000
-199,000
-55,000
-917,000
-96,000
-449,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.